Simplex Trading’s Titan Pharmaceuticals TTNP Stock Holding History

Simplex Trading’s Portfolio TTNP Stock Details TTNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-235	Closed	-$3K	–	10163
2022 Q4	$3K	Sell	235 -5	-2%	-$95	﹤0.01%	8436
2022 Q3	$5K	Buy	+240	New	+$6.2K	﹤0.01%	8823
2022 Q1	–	Sell	-215	Closed	-$4K	–	11421
2021 Q4	$4K	Sell	215 -60	-22%	-$1.81K	﹤0.01%	9716
2021 Q3	$14K	Sell	275 -5	-2%	-$219	﹤0.01%	8734
2021 Q2	$14K	Buy	280 +274	+4,567%	+$13.7K	﹤0.01%	8886
2021 Q1	$37K	Sell	6 -18	-75%	-$1.19K	﹤0.01%	6942
2020 Q4	$154K	Buy	+24	New	+$1.9K	﹤0.01%	4956
2020 Q3	–	Hold	0	–	-$1K	–	8538
2020 Q2	–	Hold	0	–	–	–	7416
2020 Q1	–	Sell	-2	Closed	-$19K	–	8297
2019 Q4	$19K	Sell	2 -1	-33%	-$120	﹤0.01%	5994
2019 Q3	$56K	Sell	3 -3	-50%	-$1.35K	﹤0.01%	4912
2019 Q2	$448K	Buy	6 +2	+50%	+$1.83K	﹤0.01%	2671
2019 Q1	$385K	Buy	+4	New	+$3.88K	﹤0.01%	2932
2016 Q4	–	Hold	0	–	-$7K	–	6547
2016 Q3	–	Hold	0	–	–	–	3990
2016 Q2	–	Hold	0	–	–	–	4284

Other funds holding TTNP

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

LFA

Level Financial Advisors East Amherst, New York $448M AUM 16.6% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Simplex Trading's TTNP Position: Q3 2022 in Review

Simplex Trading sold out of Titan Pharmaceuticals (TTNP) in Q3 2022, closing a stake of 24 shares — an estimated $620 sold.

Simplex Trading first reported a position in TTNP in Q2 2016 and held it in 8 quarters. The position peaked at $11K in Q2 2016. 18 funds tracked by Wall St. Rank hold TTNP as of Q3 2022.

Simplex Trading reported no remaining Titan Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Simplex Trading sold 24 Titan Pharmaceuticals shares in Q3 2022, an estimated $620.
Simplex Trading first reported a position in Titan Pharmaceuticals in Q2 2016 and held it in 8 quarters.
Simplex Trading's Titan Pharmaceuticals position peaked at $11K in Q2 2016.
18 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.